Neurocrine Biosciences (NBIX) Return on Invested Capital [ROIC] (2020 - 2024)
Neurocrine Biosciences (NBIX) reported Return on Invested Capital [ROIC] of 15.09% for Q4 2024, up 6.85 percentage points from 8.25% a year earlier but down 1.29 percentage points from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Return on Invested Capital [ROIC] (2020 - 2024) Analysis & Trends
For FY2024, Neurocrine Biosciences posted Return on Invested Capital [ROIC] of 16.05%, up 7.24 percentage points from FY2023.
- Return on Invested Capital [ROIC] has a four-year change of +1.04 percentage points (FY2020 to FY2024).
- By year, Return on Invested Capital [ROIC] came in at 8.82% in FY2023 (-2.25 pp), 11.06% in FY2022 (+3.82 pp), 7.25% in FY2021 (-7.76 pp) and 15.01% in FY2020.
- Five-year quarterly Return on Invested Capital [ROIC] spans a low of 5.31% in Q1 2023 and a high of 16.38% in Q3 2024.
- Year over year, Return on Invested Capital [ROIC] has now increased in each of the last four quarters, with an average year-over-year change of +6.75 percentage points over the last five quarters.
- Per Business Quant data, the three quarters before Q4 2024 came in at 16.38% (Q3 2024), 16.22% (Q2 2024) and 14.88% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 30.89% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.57% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 24.28% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.52% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 23.11% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 15.60% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.11% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 12.34% |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 15.09% |
| Sep 30, 2024 | 16.38% |
| Jun 30, 2024 | 16.22% |
| Mar 31, 2024 | 14.88% |
| Dec 31, 2023 | 8.25% |
| Sep 30, 2023 | 7.38% |
| Jun 30, 2023 | 6.12% |
| Mar 31, 2023 | 5.31% |
| Dec 31, 2022 | 10.02% |
| Dec 31, 2020 | 13.84% |
| Sep 30, 2020 | 10.18% |
API Access
Neurocrine Biosciences Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();